Biofrontera (BFRI) Financial Statements

206 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently $13.40M. The company's EPS TTM is $-1.47; its P/E ratio is 0.29; Biofrontera is scheduled to report earnings on May 8, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Mar 22
Income Statement
Total Revenue	$ 41.70M	$ 37.30M	$ 34.07M	$ 28.67M	$ 24.10M
Gross Profit	$ 31.59M	$ 18.70M	$ 16.63M	$ 13.49M	$ 11.36M
Operating Income	$ -11.35M	$ -17.21M	$ -22.68M	$ -18.58M	$ -25.20M
EBITDA	$ -10.48M	$ -14.44M	$ -18.45M	$ 934.00K	$ -36.76M
Net Income	$ -10.54M	$ -17.76M	$ -20.13M	$ -640.00K	$ -37.71M
Balance Sheet
Cash & Short-Term Investments	$ 6.39M	$ 5.91M	$ 1.42M	$ 27.76M	$ 24.55M
Total Assets	$ 28.56M	$ 22.10M	$ 27.93M	$ 50.88M	$ 53.22M
Total Debt	$ 6.16M	$ 4.92M	$ 5.40M	$ 1.35M	$ 0.00
Net Debt	$ -231.00K	$ -983.00K	$ 4.06M	$ -15.86M	$ -24.55M
Total Liabilities	$ 18.08M	$ 17.67M	$ 23.14M	$ 27.01M	$ 41.88M
Stockholders' Equity	$ 10.48M	$ 4.43M	$ 4.79M	$ 23.88M	$ 11.34M
Cash Flow
Free Cash Flow	$ -13.36M	$ -10.33M	$ -24.90M	$ -16.24M	$ -26.73M
Operating Cash Flow	$ -13.36M	$ -10.27M	$ -24.89M	$ -16.20M	$ -26.71M
Investing Cash Flow	$ 3.00M	$ -3.00K	$ 619.00K	$ -5.16M	$ -11.00K
Financing Cash Flow	$ 10.85M	$ 14.84M	$ 8.41M	$ 14.02M	$ 43.19M

Currency in USD

Biofrontera Earnings and Revenue History

Income Statement >

Biofrontera Debt to Assets

Balance Sheet >

Biofrontera Cash Flow

Cash Flow >

Biofrontera Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >